No WHO approval for Bharat Biotech' Covaxin as panel wants more details

The World Health Organization (WHO) seeks 'additional clarifications' from Bharat Biotech for Covaxin to conduct a final 'risk-benefit assessment' for emergency use listing of the vaccine.